Animal model pharmacokinetics and pharmacodynamics: a critical review.
about
Population pharmacokinetics of liposomal amphotericin B in pediatric patients with malignant diseasesIn vivo pharmacodynamic characterization of a novel plectasin antibiotic, NZ2114, in a murine infection modelAlternative strategies for proof-of-principle studies of antibacterial agentsImplementation of pharmacokinetic and pharmacodynamic strategies in early research phases of drug discovery and development at Novartis Institute of Biomedical ResearchComparison of Active Drug Concentrations in the Pulmonary Epithelial Lining Fluid and Interstitial Fluid of Calves Injected with Enrofloxacin, Florfenicol, Ceftiofur, or TulathromycinThe pharmacokinetics and pharmacodynamics of the carbapanemes: focus on doripenemIn-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleriPharmacokinetics-pharmacodynamics analysis of bicyclic 4-nitroimidazole analogs in a murine model of tuberculosisIn Vivo Pharmacokinetics/Pharmacodynamics of Cefquinome in an Experimental Mouse Model of Staphylococcus Aureus Mastitis following Intramammary InfusionComprehensive behavioral testing in the R6/2 mouse model of Huntington's disease shows no benefit from CoQ10 or minocyclineMutant prevention concentration, pharmacokinetic-pharmacodynamic integration, and modeling of enrofloxacin data established in diseased buffalo calves.Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: characterization and applicability to diverse experimental models of infectious diseasesAttenuation of colistin bactericidal activity by high inoculum of Pseudomonas aeruginosa characterized by a new mechanism-based population pharmacodynamic model.Pharmacokinetic and pharmacodynamic modeling of cyadox against Clostridium perfringens in swine.In vivo comparison of the pharmacodynamic targets for echinocandin drugs against Candida species.Intra- and extracellular activities of dicloxacillin against Staphylococcus aureus in vivo and in vitro.Antimicrobial breakpoints for gram-negative aerobic bacteria based on pharmacokinetic-pharmacodynamic models with Monte Carlo simulationConcentrations in plasma, urinary excretion, and bactericidal activity of linezolid (600 milligrams) versus those of ciprofloxacin (500 milligrams) in healthy volunteers receiving a single oral doseSafety and clinical pharmacokinetics of nemonoxacin, a novel non-fluorinated quinolone, in healthy Chinese volunteers following single and multiple oral doses.Impact of MIC range for Pseudomonas aeruginosa and Streptococcus pneumoniae on the ceftolozane in vivo pharmacokinetic/pharmacodynamic target.In vivo pharmacodynamics of new lipopeptide MX-2401Novel carbapenem antibiotics for parenteral and oral applications: in vitro and in vivo activities of 2-aryl carbapenems and their pharmacokinetics in laboratory animals.In vivo activities of ceftolozane, a new cephalosporin, with and without tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae, including strains with extended-spectrum β-lactamases, in the thighs of neutropenic mice.Pharmacokinetic-pharmacodynamic comparison of amphotericin B (AMB) and two lipid-associated AMB preparations, liposomal AMB and AMB lipid complex, in murine candidiasis models.Protection Afforded by Fluoroquinolones in Animal Models of Respiratory Infections with Bacillus anthracis, Yersinia pestis, and Francisella tularensis.Pharmacodynamics of a new cephalosporin, PPI-0903 (TAK-599), active against methicillin-resistant Staphylococcus aureus in murine thigh and lung infection models: identification of an in vivo pharmacokinetic-pharmacodynamic target.Pharmacokinetic study on pradofloxacin in the dog - comparison of serum analysis, ultrafiltration and tissue sampling after oral administrationImproving outcomes of neuroprotection by minocycline: guides from cell culture and intracerebral hemorrhage in miceEfficacy of BB-83698, a novel peptide deformylase inhibitor, in a mouse model of pneumococcal pneumonia.In vivo pharmacodynamics of antifungal drugs in treatment of candidiasis.Quantitative analysis of gentamicin, azithromycin, telithromycin, ciprofloxacin, moxifloxacin, and oritavancin (LY333328) activities against intracellular Staphylococcus aureus in mouse J774 macrophagesEstablishment of a bacterial infection model using the European honeybee, Apis mellifera L.Novel approach to optimize synergistic carbapenem-aminoglycoside combinations against carbapenem-resistant Acinetobacter baumanniiPharmacokinetics/pharmacodynamics of colistin and imipenem on mucoid and nonmucoid Pseudomonas aeruginosa biofilms.Fluoroquinolone AUIC break points and the link to bacterial killing rates. Part 1: In vitro and animal models.Response of a clinical Escherichia coli strain to repeated cefquinome exposure in a piglet tissue-cage model.In vivo pharmacokinetic/pharmacodynamic profiles of valnemulin in an experimental intratracheal Mycoplasma gallisepticum infection model.In vivo pharmacodynamic activity of the glycopeptide dalbavancinPharmacodynamics of TD-1792, a novel glycopeptide-cephalosporin heterodimer antibiotic used against Gram-positive bacteria, in a neutropenic murine thigh modelIn vivo antimicrobial activity of marbofloxacin against Pasteurella multocida in a tissue cage model in calves.
P2860
Q24542404-21DA829A-90BC-4BE7-9233-D252DC7599D0Q24654780-1F8FFA28-C7A7-48ED-BB09-BB601E2F9FDFQ26850895-D6266F87-822B-4FD9-9702-8DB026F8E645Q27024682-BA9EFCC5-DAD4-407E-BE84-02CAEAC1C7F6Q27322047-0C7DA090-1CA2-4A61-9D3A-2F25C5C984ADQ28289744-4E76B49C-C1E8-449A-B891-EF945FE6EF1AQ28304841-5150DE69-D567-4A34-8D34-38E4725742FAQ28542435-52FB9376-BA31-41EB-A5B9-B17B30BB825CQ28552364-B02F98E8-02A0-46A7-B788-B8C0E65811D8Q28748449-A7AE6B9C-83FB-4692-BDE4-846F087FD5F4Q30911044-BB5650A4-B9A8-4913-96B8-D7B0843A52B8Q33236887-D64D2F2B-39B2-4EC8-92B8-81DA324EC6EAQ33826267-C433242A-843D-46B8-B97E-1D72DAC9C556Q33826396-5DF4BA41-69D0-412F-9184-B0538104F9F7Q33876423-0272215B-499D-41C5-9BFE-5F32625C8A9EQ33876454-6FD0EF1C-4EAE-40ED-87FB-DEF630C8DFAEQ34188814-6589712A-A691-4F0D-BC05-201B7DEDA10CQ34230275-25E281D5-30E5-4FAF-A391-1D5C06C7DC2EQ34278283-9853AA04-064C-45D6-82B7-92CD7F9151E6Q34299064-8DBC0D34-3F5C-4623-AFBE-B2BA98B149DCQ34309486-9362EE29-D8DD-4E41-A1BF-8518FB556D4FQ34311384-FDD71D96-CE44-4581-850B-6A13D99D0573Q34320027-B52C2E59-FF09-4726-829F-FACF268AF514Q34352186-272B9F5A-FEC2-49D7-ABA7-284A4FB05FBBQ34368520-5A7AB91B-525E-49C9-99D1-19C1E0A74040Q34510488-008BE198-442D-4659-AC4C-E0043FA8B64BQ34587450-AFB4DA78-0468-4A5A-8101-2961C031B3F3Q34659673-26B9E3D7-DB42-4079-B2A6-619C69094540Q35006050-5C1C52ED-1EFC-4E58-B72F-EC11A3CA6D70Q35091285-6FC36716-5B99-4BD8-9F6C-5304078F1BCAQ35102754-212B8784-FB01-4B8B-A447-D3394A91ABEEQ35108350-26DF86E9-6CB6-4840-8C3A-0D99C6807E66Q35168931-FDE007CD-B34B-4754-B021-A92434DC3976Q35191390-B53766DA-F2E0-42BF-BF0F-CEEDB3D37945Q35201049-53755DA0-C0BC-4811-B0DD-7CCB9819850FQ35712872-69987B91-E031-4EB8-89E2-5CC50CA42C32Q35746225-077A578F-4298-44CB-9423-23FECF64647AQ35759076-BF9241BB-5BAE-4334-AF9C-0EDCC0A22128Q35806450-2A589BC7-E4CA-48EC-BF32-5A23383BA523Q35884208-3ED2E924-DE1C-4F58-9114-B8ADE399ECAA
P2860
Animal model pharmacokinetics and pharmacodynamics: a critical review.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Animal model pharmacokinetics and pharmacodynamics: a critical review.
@ast
Animal model pharmacokinetics and pharmacodynamics: a critical review.
@en
Animal model pharmacokinetics and pharmacodynamics: a critical review.
@nl
type
label
Animal model pharmacokinetics and pharmacodynamics: a critical review.
@ast
Animal model pharmacokinetics and pharmacodynamics: a critical review.
@en
Animal model pharmacokinetics and pharmacodynamics: a critical review.
@nl
prefLabel
Animal model pharmacokinetics and pharmacodynamics: a critical review.
@ast
Animal model pharmacokinetics and pharmacodynamics: a critical review.
@en
Animal model pharmacokinetics and pharmacodynamics: a critical review.
@nl
P1476
Animal model pharmacokinetics and pharmacodynamics: a critical review.
@en
P2093
P304
P356
10.1016/S0924-8579(02)00022-5
P577
2002-04-01T00:00:00Z